Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Review

Published on 29 Feb 2024

Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications

in Gastrointestinal and Hepatic Pharmacology

Yongkang Cheng
Sansan Feng
Chuqiao Sheng
Chunfeng Yang
Yumei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1354809

13,588 views
21 citations

Original Research

Published on 23 Feb 2024

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

in Gastrointestinal and Hepatic Pharmacology

Yue Chen
Yutao Wang
Jin Lei
Bowen Chen
Xinfeng Zhang
Liangzheng Chang
Zhangli Hu
Yun Wang
Yinying Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364924

3,106 views
2 citations

Review

Published on 23 Feb 2024

Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration

in Gastrointestinal and Hepatic Pharmacology

Evgenia Koureta
Evangelos Cholongitas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343587

11,426 views
8 citations

Original Research

Published on 23 Feb 2024

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients

in Gastrointestinal and Hepatic Pharmacology

Jingwei Zhu
Zhe Wang
Xiaotong Sun
Dan Wang
Xinbo Xu
Liping Yang
Jiangdong Du
Zhimei Zhou
Yanhua Qi
Linfeng Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358262

2,764 views
4 citations

Clinical Trial

Published on 19 Feb 2024

The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial

in Gastrointestinal and Hepatic Pharmacology

Muhammad Raza Shah
Samreen Fatima
Sehrosh Naz Khan
Shafiullah
Zahid Azam
Hafeezullah Shaikh
Shahid Majid
He Chengdong
Zhou Daijun
Wei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1293272

5,407 views
2 citations

Original Research

Published on 15 Feb 2024

A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics

in Gastrointestinal and Hepatic Pharmacology

Menghan Zhang
Qi Wang
Gongming Zhang
Guangming Li
Ronghua Jin
Huichun Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360478

2,131 views

Original Research

Published on 14 Feb 2024

Network pharmacology and gut microbiota insights: unraveling Shenling Baizhu powder’s role in psoriasis treatment

in Gastrointestinal and Hepatic Pharmacology

Bin Tang
Xuwei Zheng
Qianqian Luo
Xiong Li
Yujie Yang
Yang Bi
Yonggen Chen
Ling Han
Haiming Chen
Chuanjian Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362161

8,192 views
13 citations

Original Research

Published on 01 Feb 2024

Chishao (Paeoniae Radix Rubra) alleviates intra-hepatic cholestasis by modulating NTCP in rats

in Gastrointestinal and Hepatic Pharmacology

Xiaoqi Sun
Jing Fang
Nanyuan Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341651

2,457 views
5 citations

Original Research

Published on 01 Feb 2024

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro

in Gastrointestinal and Hepatic Pharmacology

Teng Zhang
Yong Zhou
Yan Zhang
De-Guo Wang
Qiu-Yue Lv
Wen Wang
Ya-Ping Bai
Qiang Hua
Li-Qun Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347274

2,777 views
6 citations

Editorial

Published on 15 Jan 2024

Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases

in Gastrointestinal and Hepatic Pharmacology

Ebenezeri Erasto Ngowi
Yong Gao
Xiaoying Yang
Aijun Qiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364290

1,803 views
1 citation

Original Research

Published on 11 Jan 2024

Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression

in Gastrointestinal and Hepatic Pharmacology

Lyndsay E. A. Young
Paul J. Nietert
Rachel Stubler
Caroline G. Kittrell
Grace Grimsley
David N. Lewin
Anand S. Mehta
Chadi Hajar
Katherine Wang
Elizabeth C. O’Quinn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1337319

5,327 views
9 citations

Systematic Review

Published on 11 Jan 2024

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Yongqi Dong
Hongyan Xu
Zhihuan Zhang
Zhihang Zhou
Qiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1304552

9,094 views
17 citations

Systematic Review

Published on 10 Jan 2024

A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace

in Gastrointestinal and Hepatic Pharmacology

Yi Chen
Jiaqi Zhang
Junling Wu
Hanwen Zhang
Zhe Luan
Zhizhuang Zhao
Congyong Li
Yiming Zhao
Hu Zhang
Shufang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1322319

5,088 views
8 citations

Original Research

Published on 09 Jan 2024

Dimethyloxalylglycine pretreatment of living donor alleviates both donor and graft liver ischemia-reperfusion injury in rats

in Gastrointestinal and Hepatic Pharmacology

Degong Jia
Minjie Zhao
Jiefu Luo
Shengwei Li
Jianping Gong
Mingxiang Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1341575

2,323 views

Editorial

Published on 08 Jan 2024

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

in Gastrointestinal and Hepatic Pharmacology

Eleonora Lai
Jessica Williams
Raquel Abalo
Daniela Gabbia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1359135

1,457 views

Systematic Review

Published on 08 Jan 2024

Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Xin Chi
Xiu Sun
Danying Cheng
Shunai Liu
Calvin Q. Pan
Huichun Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274261

3,075 views
6 citations

Original Research

Published on 05 Jan 2024

Role of symbiotic microbiota dysbiosis in the progression of chronic kidney disease accompanied with vascular calcification

in Gastrointestinal and Hepatic Pharmacology

Mengying Sun
Yilong Fang
Jianhua Zheng
Guojuan Shi
Junli Guo
Xinzhou Zhang
Rui Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306125

5,036 views
9 citations

Original Research

Published on 04 Jan 2024

Unlocking the hepatoprotective potential of the parasitic plant Orobanche foetida Poir. aqueous extract against CCl4-induced liver injury in rat

in Gastrointestinal and Hepatic Pharmacology

Arij Bedoui
Afoua Mufti
Anouar Feriani
Hanene Baccari
Amal Bouallegue
Mohamed Kharrat
Mansour Sobeh
Moez Amri
Zouhaier Abbes

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1320062

4,210 views
9 citations

Original Research

Published on 21 Dec 2023

Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B

in Gastrointestinal and Hepatic Pharmacology

Hai-Na Fan
Zhi-Min Zhao
Kai Huang
Xiao-Ning Wang
Yun-Kai Dai
Cheng-Hai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1329266

3,795 views
4 citations

Review

Published on 15 Dec 2023

Macrophage cytotherapy on liver cirrhosis

in Gastrointestinal and Hepatic Pharmacology

Dabing Ping
Yuan Peng
Xudong Hu
Chenghai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265935

7,628 views
5 citations

Systematic Review

Published on 13 Dec 2023

Effect of potassium-competitive acid blockers on human gut microbiota: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Meng-Ling Ouyang
Shu-Peng Zou
Qian Cheng
Xuan Shi
Ya-Zheng Zhao
Ming-Hui Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269125

4,037 views
7 citations

Review

Published on 12 Dec 2023

Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis

in Gastrointestinal and Hepatic Pharmacology

Zhen Li
Junfeng Zhu
Hao Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1303012

5,143 views
11 citations

Original Research

Published on 08 Dec 2023

Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: a prospective cohort study

in Gastrointestinal and Hepatic Pharmacology

Jinyu Zhao
Liang Tian
Bin Xia
Ningning Mi
Qiangsheng He
Man Yang
Danni Wang
Siqing Wu
Zijun Li
Shiyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244563

14,157 views
8 citations

Correction

Published on 07 Dec 2023

Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis

in Gastrointestinal and Hepatic Pharmacology

Jin Xiao
Yan-ni Zhou
Yan-lin Yang
Li He
Ke-kai Wang
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1330698

945 views

1,288 articles

articles

Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients

The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial

A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics

Network pharmacology and gut microbiota insights: unraveling Shenling Baizhu powder’s role in psoriasis treatment

Chishao (Paeoniae Radix Rubra) alleviates intra-hepatic cholestasis by modulating NTCP in rats

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro

Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases

Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace

Dimethyloxalylglycine pretreatment of living donor alleviates both donor and graft liver ischemia-reperfusion injury in rats

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis

Role of symbiotic microbiota dysbiosis in the progression of chronic kidney disease accompanied with vascular calcification

Unlocking the hepatoprotective potential of the parasitic plant Orobanche foetida Poir. aqueous extract against CCl4-induced liver injury in rat

Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B

Macrophage cytotherapy on liver cirrhosis

Effect of potassium-competitive acid blockers on human gut microbiota: a systematic review and meta-analysis

Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis

Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: a prospective cohort study

Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis